When you put all of that together, we've got somewhere north of $8 billion that was available, already appropriated, and which we are not yet up against spending. What I would say to the member, though, is that clearly there are ongoing costs associated with COVID-19. That includes—and they are within the Estimates as well—matters such as vaccinations, that includes matters such as those to do with managed isolation and quarantine and so on, and so there is an ongoing need for expenditure in the response to COVID-19. But in terms of where we are now and what is being needed, we have the resources that we need.